It is locatedin Benniu Biomedical Industrial Park. Its campuscovers an area of over 100,000㎡. The total investment for this siteis over 800 million yuan.The investment has resulted in a R&D/QC building, and a formulation workshop. Our Formulation R&D Laboratory is equipped with advanced instruments, which can fulfill the R&D tasks for both general solid dosage forms and sustained-and-controlled release solid dosage forms.

Jiangsu Shanglaite Pharmaceutical Chemical Materials Co., Ltd. was established in 2003, covering an area of over 120000 square meters. It is a joint-stock enterprise that integrates science, industry, and trade. The company is located in the coastal industrial park of Jiangsu Province, with complete facilities. Currently, the company's main products include products such as m-trifluoromethylphenol and p-nitrobenzamide.

Dalian New Sunlight Material Technology Co., Ltd. was established in February 2020, with a planned land area of 180 acres and a total investment of 430 million yuan. The main products are high-end polyimide monomers and pharmaceutical intermediates, widely used in fields such as national defense and military industry, aerospace, electronic information, and biomedicine.

Dongying New Sunlight Material Technology Co., Ltd. was established in May 2023 and is located in the Chemical Industry Park (Diaokou Township) of Lijin Binhai New Area, with a registered capital of 150 million yuan. The project is planned to use 203 acres of land with a total investment of 580 million yuan.